Employer Actions Sample Clauses

Employer Actions a. The Employer will not discharge, discipline, discriminate against, or request or require rehabilitation of an Employee solely on the basis of a positive test result from the initial screening test that has not been verified by a confirmatory test. b. The Employer shall observe Employee rights under applicable sections of this article. c. Nothing in this article limits the right of the Employer to discipline or discharge an Employee on grounds other than those set forth in Section 31.7(j).
Sample 1Sample 2Sample 3See All (9)
AutoNDA by SimpleDocs
Employer Actions. Any action by the Employer pursuant to the provisions of the Plan shall be evidenced by appropriate resolution or by written instrument executed by any person authorized by the Employer to take such action.
Sample 1Sample 2Sample 3See All (6)
Employer Actions. 24.1 In the event the Employer implements any changes in benefits, privileges or working conditions that have been established by the Employer and not otherwise provided by this Agreement and which benefits, privileges or working conditions are mandatory subjects for bargaining, the Union may challenge such through the procedure established by State law. 24.2 Provided the Employer can show legal justification for making such change, the arbitrator may not affect or alter the Employer's action. 24.3 The parties agree the use of the procedure herein shall be the final and binding resolution of the matter unless the parties agree to negotiate further. 24.4 It is understood that benefits and privileges given specifically by this Agreement will supersede benefits and privileges of the same nature extended prior to this Agreement.
Sample 1See All (4)
Employer Actions. In the event of a merger, sale, closure or other transfer of ownership of St. Xxxx Medical Center, the employer shall: a) inform the prospective acquiring purchaser of the existence of this collective bargaining agreement and of its general terms and conditions b) provide purchaser with a copy of the agreement. In the event of program closure for any reason whatsoever, St. Xxxx Medical Center shall follow all ACGME guidelines including "program closure/reduction" and make every reasonable effort to place any affected residents in another accredited residency training program. In the event of program closure or termination of the residency training program, St. Xxxx Medical Center will continue to pay and administer benefits to bargaining unit members until separation from St. Xxxx Medical Center.
Sample 1Sample 2
Employer Actions. An employee who has completed her/his probationary period may be suspended, discharged, or disciplined but only for just cause.
Sample 1
Employer Actions. In the event of a merger, sale, closure or other transfer of ownership of California Hospital Medical Center, the employer shall: a) inform the prospective acquiring purchaser of the existence of this collective bargaining agreement and of its general terms and conditions b) provide purchaser with a copy of the agreement. In the event of program closure for any reason whatsoever, California Hospital Medical Center shall follow all ACGME guidelines including "program closure/reduction" and make every reasonable effort to place any affected residents in another accredited residency training program. In the event of program closure or termination of the residency training program, California Hospital Medical Center will continue to pay and administer benefits to bargaining unit members until separation from California Hospital Medical Center.
Sample 1
Employer Actions. In the event of a merger, sale, closure or other transfer of ownership of St. Mary's Medical Center, the employer shall: a) inform the prospective acquiring purchaser of the existence of this collective bargaining agreement and of its general terms and conditions b) provide purchaser with a copy of the agreement. In the event of program closure for any reason whatsoever, St. Mary's Medical Center shall notify each affected resident and the Union, and shall follow all ACGME guidelines including “program closure/reduction” and make every reasonable effort to place any affected residents in another accredited residency training program. At the request of the Union, the Medical Center and the Union shall meet and confer in regards to the impact of the closure on the affected residents including but not limited to the status of Centers for Medicare and Medicaid Services (CMS) funding concerning “orphaned” residents. In the event of program closure or termination of the residency training program, St. Mary's Medical Center will continue to pay and administer benefits to bargaining unit members until separation from St. Mary's Medical Center.
Sample 1
AutoNDA by SimpleDocs
Employer Actions. In the event of a merger, sale, closure or other transfer of ownership of St. Mary's Medical Center, the employer shall: a) inform the prospective acquiring purchaser of the existence of this collective bargaining agreement and of its general terms and conditions b) provide purchaser with a copy of the agreement. In the event of program closure for any reason whatsoever, St. Mary's Medical Center shall follow all ACGME guidelines including “program closure/reduction” and make every reasonable effort to place any affected residents in another accredited residency training program. In the event of program closure or termination of the residency training program, St. Mary's Medical Center will continue to pay and administer benefits to bargaining unit members until separation from St. Mary's Medical Center.
Sample 1
Employer Actions. 85 3.12.3 Execution of Receipts and Releases . . . . . . . . . . . 85 3.12.4 Rights of Participants Limited . . . . . . . . . . . . . 85 3.12.5
Sample 1

Related to Employer Actions

  • Other Actions In order to further insure the attachment, perfection and priority of, and the ability of the Collateral Agent to enforce, the Security Interest, each Grantor agrees, in each case at such Grantor’s own expense, to take the following actions with respect to the following Article 9 Collateral:

  • No Inconsistent Actions The parties hereto shall not voluntarily undertake or fail to undertake any action or course of action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent of the parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this Agreement.

  • No Suits or Actions At the Closing Date no suit, action, or other proceeding shall have been threatened or instituted to restrain, enjoin, or otherwise prevent the consummation of this Agreement or the contemplated transactions.

  • Other Legal Actions The actions stipulated in this Integrity Pact are without prejudice to any other legal action that may follow in accordance with the provisions of the extant law in force relating to any civil or criminal proceedings.

  • Corrective Actions The Government will use its best efforts to ensure that each Covered Provider (i) takes, where necessary, appropriate and timely corrective actions in response to audits, (ii) considers whether the results of the Covered Provider’s audit necessitates adjustment of the Government’s records, and (iii) permits independent auditors to have access to its records and financial statements as necessary.

  • Company Actions The Company hereby consents to the Offer and represents and warrants that (a) its Board of Directors (at a meeting duly called and held), has (i) determined that the Offer and the Merger are fair to and in the best interests of the stockholders of the Company, (ii) resolved to approve the Offer and the Merger and recommend (subject to its fiduciary duties after taking into account advice of legal counsel) acceptance of the Offer and approval and adoption of this Agreement by such stockholders of the Company, (iii) taken all necessary steps to render Section 203 of the Delaware General Corporation Law (the "DGCL") inapplicable to the Merger, (iv) resolved to elect not to be subject, to the extent permitted by law, to any state takeover law other than Section 203 of the DGCL that may purport to be applicable to the Offer, the Merger or the transactions contemplated by this Agreement and (v) approved the Company Rights Agreement Amendment (as defined below), and (b) Xxxxxxxxx, Xxxxxx & Xxxxxxxx Securities Corporation ("DLJ"), the Company's financial advisor, has advised the Company's Board of Directors that, in their opinion, the consideration to be paid in the Offer and the Merger to the Company's stockholders is fair, from a financial point of view, to such stockholders. Upon commencement of the Offer, the Company shall file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 (the "Schedule 14D-9") containing the recommendations of its Board of Directors in favor of the Offer and the Merger and shall permit the inclusion in the Offer Documents of such recommendations, in each case subject to the fiduciary duties of the Board of Directors of the Company. The Company, IHK and Merger Sub will promptly correct any information provided by them for use in the Schedule 14D-9 that becomes false or misleading in any material respect, and the Company will take all steps necessary to cause the Schedule 14D-9 as so corrected to be filed with the SEC and to be disseminated to holders of shares of Company Common Stock, in each case as and to the extent required by applicable law. IHK and its counsel shall be given a reasonable opportunity to review and comment on the Schedule 14D-9 prior to its filing with the SEC. The Company agrees to provide IHK with any comments that may be received from the SEC or its staff with respect to the Schedule 14D-9 and any amendments thereto, promptly after receipt thereof.

  • Court Actions Nothing contained in this Agreement shall deny either Party the right to seek injunctive or other equitable relief from a court of competent jurisdiction in the context of a bona fide emergency or prospective irreparable harm, and such an action may be filed and maintained notwithstanding any ongoing discussions between the Parties or any ongoing arbitration proceeding. In addition, either Party may bring an action in any court of competent jurisdiction to resolve disputes pertaining to the validity, construction, scope, enforceability, infringement or other violations of Patent Rights or other intellectual property rights, and no such claim shall be subject to arbitration pursuant to Section 11.2.

  • No Inconsistent Action Seller shall not take any action that is inconsistent with its obligations under this Agreement or that could hinder or delay the consummation of the transactions contemplated by this Agreement.

  • No Legal Actions No court or governmental authority of competent jurisdiction shall have issued an order, not subsequently vacated, restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement, and no person shall have instituted an action or proceeding which shall not have been previously dismissed seeking to restrain, enjoin or prohibit the consummation of the transactions contemplated by this Agreement or seeking damages with respect thereto.

  • Infringement Actions Following an Option Exercise Date, subject to the provisions of any Voyager In-License, Genzyme shall have the sole and exclusive right, but not the obligation, to take any reasonable measures it deems appropriate with respect to any Competitive Infringement in the Genzyme Territory of any Genzyme Technology, Genzyme Collaboration Technology, Joint Collaboration Technology or Voyager Product-Specific Patent Rights, or with Voyager’s prior written consent, the Voyager Platform Patent Rights. Such measures may include (a) initiating or prosecuting an infringement, misappropriation or other appropriate suit or action (each an CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. “Infringement Action”) in the Genzyme Territory, or (b) subject to Section 11.1.5 (Genzyme Sublicense Rights), granting adequate rights and licenses to any Third Party necessary to render continued Competitive Infringement in the Genzyme Territory non-infringing. Voyager will consider in good faith any request from Genzyme to initiate an Infringement Action in the Genzyme Territory against any Third Party with respect to such Competitive Infringement of any Voyager Platform Patent Right; provided, however, that Voyager shall not be required to initiate any such Infringement Action or permit Genzyme to initiate any such Infringement Action with respect to any Voyager Platform Patent Right. Notwithstanding the foregoing, if Genzyme does not inform Voyager that it intends to either initiate such an Infringement Action or grant adequate rights and licenses to such Third Party within [***] after Genzyme’s receipt of a notice of infringement pursuant to Section 15.4.1 (Notice of Infringement), then Voyager will have the second right, but not the obligation, to initiate such Infringement Action, but solely with respect to any Voyager Technology, Voyager Collaboration Technology, or Joint Collaboration Technology.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!